Effects of COVID-19 Pandemic on the Diagnosis of Melanoma and Keratinocyte Carcinomas: a Systematic Review and Meta-analysis
Metadatos
Mostrar el registro completo del ítemAutor
Díaz Calvillo, Pablo; Muñoz Barba, Daniel; Ureña Paniego, Clara Amanda; Maul, Lara Valeska; Cerminara, Sara; Kostner, Lisa; Martínez López, Antonio; Arias Santiago, Salvador AntonioEditorial
MJS Publishing
Materia
Melanoma Squamous cell carcinoma Basal cell carcinoma
Fecha
2024-03-14Referencia bibliográfica
Díaz-Calvillo P, Muñoz-Barba D, Ureña-Paniego C, Maul LV, Cerminara S, Kostner L, Martínez López A, Arias-Santiago S. Effects of COVID-19 Pandemic on the Diagnosis of Melanoma and Keratinocyte Carcinomas: a Systematic Review and Meta-analysis. Acta Derm Venereol. 2024 Mar 14;104:adv19460. doi: 10.2340/actadv.v104.19460
Resumen
Since December 2019, the COVID-19 pandemic has
profoundly affected healthcare. The real effects of the
COVID-19 pandemic on skin cancer are still unclear,
more than 3 years later. This study aims to summarise
the pandemic’s impact on skin cancer diagnosis and
outcome. A systematic review and meta-analysis was
conducted, selecting studies comparing skin cancer
diagnosis
and prognosis post-pandemic with pre-pandemic
data. A total of 27 papers were reviewed including
102,263 melanomas and 271,483 keratinocyte
carcinomas. During the initial pandemic months (January–
July 2020), melanoma surgeries dropped by 29.7%
and keratinocyte carcinomas surgeries by 50.8%. Early
pandemic tumours exhibited greater thickness and
stage. In a long-term period beyond the initial months,
melanoma surgeries decreased by 9.3%, keratinocyte
carcinomas by 16.6%. No significant differences were
observed in the Breslow thickness of melanomas after
the start of the pandemic (mean difference 0.06, 95%
confidence interval –0.46, 0.58). Melanomas operated on
post-pandemic onset had an increased risk of ulceration
(odds ratio 1.35, 95% confidence interval 1.22–1.50).
Keratinocyte carcinomas showed increased thickness
and worsened stage post-pandemic. However,
studies
included were mostly retrospective and cross-sectional,
reporting diverse data. This review indicates that the
pandemic likely caused delays in skin cancer diagnosis
and treatment, potentially impacting patient outcomes.